Work Ability in Patients with Chronic Myeloid Leukemia: A Danish Nationwide Cohort Study

<b>Background/Objectives</b>: Patients with chronic myeloid leukemia (CML) have a long life expectancy due to modern treatment. However, treatment may have adverse effects that hamper work ability. <b>Methods</b>: Patients aged 25-60 years diagnosed in 2002-2020 were included in this nationwide matched cohort study examining work ability from diagnosis (index date), including the need for permanent disability compensation (flexible job or disability pension). Each patient was matched 1:5 on sex, birth year, and level of comorbidity with citizens from the general Danish population without CML. The risks of requiring flexible job and disability pension were calculated by cause-specific hazard ratios (HRs) using Cox proportional hazards regression, and the Aalen-Johansen estimator was used to determine cumulative risks. <b>Results</b>: A total of 489 patients with CML and 2445 matched comparators were included. The median age was 46 years, and males comprised 59.5% of the cohort. Matched comparators were more likely to work at index date and 1, 3, 5, and 10 years after the index date (<i>p</i> < 0.001). The HRs of requiring both flexible job (HR 8.7 (95% confidence interval (CI): 6.1;12.2, <i>p</i> < 0.001)) and disability pension (HR 3.7 (95% CI: 2.8;4.9, <i>p</i> < 0.001)) were higher among patients diagnosed with CML compared to matched comparators. The cumulative risk of requiring flexible job and disability pension also increased in patients with CML compared to matched comparators (<i>p</i> < 0.001). <b>Conclusions</b>: Patients with CML have a reduced work ability compared to the general population. More research is needed to determine the cause of their loss of ability to work.